Download PDF
CC BY-NC-ND 4.0 · Klin Padiatr 2023; 235(03): e1-e15
DOI: 10.1055/a-2039-2604
Leitlinie

Leitlinie Myokarditis der Deutschen Gesellschaft für Pädiatrische Kardiologie

Consensus statement on myocarditis in childhood – German Society for Pediatric Cardiology
Thomas Paul
1   Universitätsmedizin Göttingen Klinik für Pädiatrische Kardiologie und Intensivmedizin, Göttingen, Deutschland
,
Karin Klingel
2   Universitätshospital Tübingen, Institut für Pathologie und Neuropathologie, Tübingen, Deutschland
,
Carsten Tschöpe
3   Charité Universitätsmedizin Berlin, Kardiologie, Berlin, Deutschland
,
Harald Bertram
4   Medizinische Hochschule Hannover, Klinik für Pädiatrische Kardiologie und Pädiatrische Intensivmedizin, Hannover, Deutschland
,
Franziska Seidel
5   Charité Universitätsmedizn Berlin, Pädiatrische Kardiologie, Berlin, Deutschland
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Zusammenfassung

Diese Leitlinie präsentiert die aktuellen Handlungsanweisungen zur Diagnostik und Therapie der Myokardits im Kindesalter.

Abstract

This consensus statement presents updated recommendations on diagnosis and treatment of myocarditis in childhood

Schlüsselwörter

Myokarditis - Kindesalter - Diagnostik - Therapie

Key words

myocardits - childhood - diagnosis - treatments


Publication History

Article published online:
24 April 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Butts RJ, Boyle GJ, Deshpande SR. et al. Characteristics of Clinically Diagnosed Pediatric Myocarditis in a Contemporary Multi-Center Cohort. Pediatr Cardiol 2017; 38: 1175-1182
    CrossrefPubMedGoogle Scholar
  • 2 Putschoegl A, Auerbach S. Diagnosis, Evaluation, and Treatment of Myocarditis in Children. Pediatr Clin North Am 2020; 67: 855-874
    CrossrefPubMedGoogle Scholar
  • 3 Law YM, Lal AK, Chen S. et al. Diagnosis and Management of Myocarditis in Children: A Scientific Statement From the American Heart Association. Circulation 2021; 144: e123-e135
    PubMedGoogle Scholar
  • 4 Wu L, Ong S, Talor MV. et al. Cardiac fibroblasts mediate IL-17A-driven inflammatory dilated cardiomyopathy. J Exp Med 2014; 211: 1449-1464
    CrossrefPubMedGoogle Scholar
  • 5 Levine MC, Klugman D, Teach SJ. Update on myocarditis in children. Curr Opin Pediatr 2010; 22: 278-283
    CrossrefPubMedGoogle Scholar
  • 6 Kindermann I, Barth C, Mahfoud F. et al. Update on myocarditis. Journal of the American College of Cardiology 2012; 59: 779-792
    CrossrefPubMedGoogle Scholar
  • 7 Caforio ALP, Adler Y, Agostini C. et al. Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease. Eur Heart J 2017; 38: 2649-2662
    CrossrefPubMedGoogle Scholar
  • 8 Tschope C, Ammirati E, Bozkurt B. et al. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat Rev Cardiol 2021; 18: 169-193
    CrossrefPubMedGoogle Scholar
  • 9 Bemtgen X, Klingel K, Hufnagel M. et al. Case Report: Lymphohistiocytic Myocarditis With Severe Cardiogenic Shock Requiring Mechanical Cardiocirculatory Support in Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection. Front Cardiovasc Med 2021; 8: 716198
    CrossrefPubMedGoogle Scholar
  • 10 Belhadjer Z, Meot M, Bajolle F. et al. Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic. Circulation 2020; 142: 429-436
    CrossrefPubMedGoogle Scholar
  • 11 Son MBF, Murray N, Friedman K. et al. Multisystem Inflammatory Syndrome in Children – Initial Therapy and Outcomes. N Engl J Med 2021; 385: 23-34
    CrossrefPubMedGoogle Scholar
  • 12 Mevorach D, Anis E, Cedar N. et al. Myocarditis after BNT162b2 Vaccination in Israeli Adolescents. N Engl J Med. 2022
    PubMedGoogle Scholar
  • 13 Mevorach D, Anis E, Cedar N. et al. Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel. N Engl J Med 2021; 385: 2140-2149
    CrossrefPubMedGoogle Scholar
  • 14 Husby A, Hansen JV, Fosbol E. et al. SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study. BMJ 2021; 375: e068665
    CrossrefPubMedGoogle Scholar
  • 15 Canter CE, Simpson KE. Diagnosis and treatment of myocarditis in children in the current era. Circulation 2014; 129: 115-128
    CrossrefPubMedGoogle Scholar
  • 16 Seidel F, Holtgrewe M, Al-Wakeel-Marquard N. et al. Pathogenic Variants Associated With Dilated Cardiomyopathy Predict Outcome in Pediatric Myocarditis. Circ Genom Precis Med 2021; 14: e003250
    CrossrefPubMedGoogle Scholar
  • 17 Messroghli DR, Pickardt T, Fischer M. et al. Toward evidence-based diagnosis of myocarditis in children and adolescents: Rationale, design, and first baseline data of MYKKE, a multicenter registry and study platform. Am Heart J 2017; 187: 133-144
    CrossrefPubMedGoogle Scholar
  • 18 Dieks JK, Backhoff D, Schneider HE. et al. Lone Atrial Flutter in Children and Adolescents: Is It Really “Lone”?. Pediatr Cardiol 2021; 42: 361-369
    CrossrefPubMedGoogle Scholar
  • 19 Miyake CY, Teele SA, Chen L. et al. In-hospital arrhythmia development and outcomes in pediatric patients with acute myocarditis. The American journal of cardiology 2014; 113: 535-540
    CrossrefPubMedGoogle Scholar
  • 20 Schubert S, Opgen-Rhein B, Boehne M. et al. Severe heart failure and the need for mechanical circulatory support and heart transplantation in pediatric patients with myocarditis: Results from the prospective multicenter registry “MYKKE”. Pediatr Transplant 2019; 23: e13548
    CrossrefPubMedGoogle Scholar
  • 21 Arola A, Pikkarainen E, Sipila JO. et al. Occurrence and Features of Childhood Myocarditis: A Nationwide Study in Finland. J Am Heart Assoc 2017; 6: e005306
    CrossrefPubMedGoogle Scholar
  • 22 Klugman D, Berger JT, Sable CA. et al. Pediatric patients hospitalized with myocarditis: a multi-institutional analysis. Pediatr Cardiol 2010; 31: 222-228
    CrossrefPubMedGoogle Scholar
  • 23 Kasner M, Aleksandrov A, Escher F. et al. Multimodality imaging approach in the diagnosis of chronic myocarditis with preserved left ventricular ejection fraction (MCpEF): The role of 2D speckle-tracking echocardiography. Int J Cardiol 2017; 243: 374-378
    CrossrefPubMedGoogle Scholar
  • 24 Paulus WJ, Tschope C, Sanderson JE. et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007; 28: 2539-2550
    CrossrefPubMedGoogle Scholar
  • 25 Gursu HA. Cetin, II, Azak E et al. The assessment of treatment outcomes in patients with acute viral myocarditis by speckle tracking and tissue Doppler methods. Echocardiography 2019; 36: 1666-1674
    CrossrefPubMedGoogle Scholar
  • 26 Kasner M, Gaub R, Sinning D. et al. Global strain rate imaging for the estimation of diastolic function in HFNEF compared with pressure-volume loop analysis. Eur J Echocardiogr 2010; 11: 743-751
    CrossrefPubMedGoogle Scholar
  • 27 Wisotzkey BL, Soriano BD, Albers EL. et al. Diagnostic role of strain imaging in atypical myocarditis by echocardiography and cardiac MRI. Pediatr Radiol 2018; 48: 835-842
    CrossrefPubMedGoogle Scholar
  • 28 Jhamnani S, Fuisz A, Lindsay J. The spectrum of electrocardiographic manifestations of acute myocarditis: an expanded understanding. J Electrocardiol 2014; 47: 941-947
    CrossrefPubMedGoogle Scholar
  • 29 Ichikawa R, Sumitomo N, Komori A. et al. The follow-up evaluation of electrocardiogram and arrhythmias in children with fulminant myocarditis. Circ J 2011; 75: 932-938
    CrossrefPubMedGoogle Scholar
  • 30 Cooper LT. Myocarditis. N Engl J Med 2009; 360: 1526-1538
    CrossrefPubMedGoogle Scholar
  • 31 Durani Y, Egan M, Baffa J. et al. Pediatric myocarditis: presenting clinical characteristics. Am J Emerg Med 2009; 27: 942-947
    CrossrefPubMedGoogle Scholar
  • 32 Messroghli DR, Moon JC, Ferreira VM. et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson 2017; 19: 75
    CrossrefPubMedGoogle Scholar
  • 33 Ferreira VM, Schulz-Menger J, Holmvang G. et al. Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations. Journal of the American College of Cardiology 2018; 72: 3158-3176
    CrossrefPubMedGoogle Scholar
  • 34 Pitak B, Opgen-Rhein B, Schubert S. et al. Cardiovascular magnetic resonance in children with suspected myocarditis: current practice and applicability of adult protocols. Cardiology in the young 2022; 1-9
    PubMedGoogle Scholar
  • 35 Caforio AL, Pankuweit S, Arbustini E. et al Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2013; 34: 2636-2648 2648a-2648d
    CrossrefPubMedGoogle Scholar
  • 36 Seferovic PM, Tsutsui H, McNamara DM. et al. Heart Failure Association, Heart Failure Society of America, and Japanese Heart Failure Society Position Statement on Endomyocardial Biopsy. J Card Fail 2021; 27: 727-743
    CrossrefPubMedGoogle Scholar
  • 37 Pollack A, Kontorovich AR, Fuster V. et al. Viral myocarditis – diagnosis, treatment options, and current controversies. Nat Rev Cardiol 2015; 12: 670-680
    CrossrefPubMedGoogle Scholar
  • 38 Mueller GC, Michel-Behnke I, Knirsch W. et al. Feasibility, safety and diagnostic impact of endomyocardial biopsies for the diagnosis of myocardial disease in children and adolescents. EuroIntervention 2018; 14: 1089-1095
    CrossrefPubMedGoogle Scholar
  • 39 Pophal SG, Sigfusson G, Booth KL. et al. Complications of endomyocardial biopsy in children. Journal of the American College of Cardiology 1999; 34: 2105-2110
    CrossrefPubMedGoogle Scholar
  • 40 Frey T, Arain N. Pediatric Viral Myocarditis – A Review. S D Med 2018; 71: 29-34
    PubMedGoogle Scholar
  • 41 Pankuweit S, Klingel K. Viral myocarditis: from experimental models to molecular diagnosis in patients. Heart Fail Rev 2013; 18: 683-702
    CrossrefPubMedGoogle Scholar
  • 42 Degener F, Salameh A, Manuylova T. et al. First paediatric cohort for the evaluation of inflammation in endomyocardial biopsies derived from congenital heart surgery. Int J Cardiol 2020; 303: 36-40
    CrossrefPubMedGoogle Scholar
  • 43 Bultmann BD, Sotlar K, Klingel K. Parvovirus B19. N Engl J Med 2004; 350: 2006-2007 author reply 2006-7
    CrossrefPubMedGoogle Scholar
  • 44 Bock CT, Klingel K, Kandolf R. Human parvovirus B19-associated myocarditis. N Engl J Med 2010; 362: 1248-1249
    CrossrefPubMedGoogle Scholar
  • 45 Elsanhoury A, Kühl U, Stautner B. et al. The Spontaneous Course of Human Herpesvirus 6 DNA-Associated Myocarditis and the Effect of Immunosuppressive Intervention. Viruses 2022; 14: 299
    CrossrefPubMedGoogle Scholar
  • 46 Tschope C, Elsanhoury A, Schlieker S. et al. Immunosuppression in inflammatory cardiomyopathy and parvovirus B19 persistence. Eur J Heart Fail 2019; 21: 1468-1469
    CrossrefPubMedGoogle Scholar
  • 47 Soler-Botija C, Galvez-Monton C, Bayes-Genis A. Epigenetic Biomarkers in Cardiovascular Diseases. Front Genet 2019; 10: 950
    CrossrefPubMedGoogle Scholar
  • 48 Halliday BP, Cleland JGF, Goldberger JJ. et al. Personalizing Risk Stratification for Sudden Death in Dilated Cardiomyopathy: The Past, Present, and Future. Circulation 2017; 136: 215-231
    CrossrefPubMedGoogle Scholar
  • 49 Shah SJ, Katz DH, Selvaraj S. et al. Phenomapping for novel classification of heart failure with preserved ejection fraction. Circulation 2015; 131: 269-279
    CrossrefPubMedGoogle Scholar
  • 50 Kannan S, Miyamoto M, Lin BL. et al. Large Particle Fluorescence-Activated Cell Sorting Enables High-Quality Single-Cell RNA Sequencing and Functional Analysis of Adult Cardiomyocytes. Circ Res 2019; 125: 567-569
    CrossrefPubMedGoogle Scholar
  • 51 Mahfoud F, Gartner B, Kindermann M. et al. Virus serology in patients with suspected myocarditis: utility or futility?. Eur Heart J 2011; 32: 897-903
    CrossrefPubMedGoogle Scholar
  • 52 Pelliccia A, Sharma S, Gati S. et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. Eur Heart J 2021; 42: 17-96
    CrossrefPubMedGoogle Scholar
  • 53 Michel-Behnke I, Thul J, Murin P. et al. Leitlinie DGPK: Akute Herzinsuffizienz und mechanische Kreislaufunterstützung. https://wwwdgpkorg/fileadmin/user_upload/Leitlinien/LLAHI_2020-finalpdf 2020
    PubMed
  • 54 Tschope C, Van Linthout S, Jager S. et al. Modulation of the acute defence reaction by eplerenone prevents cardiac disease progression in viral myocarditis. ESC Heart Fail 2020; 7: 2838-2852
    CrossrefPubMedGoogle Scholar
  • 55 Solomon SD, McMurray JJV, Anand IS. et al. Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction. N Engl J Med 2019; 381: 1609-1620
    CrossrefPubMedGoogle Scholar
  • 56 Rickers C, Läer S, Diller GP. et al. Leitlinie DGPK: Chronische Herzinsuffizienz. https://wwwdgpkorg/fileadmin/user_upload/Leitlinien/LL_Chronische_Herzinsuffizienz_Nov_2015_Rickerspdf 2015
    PubMed
  • 57 Paul T, Ruschewski W, Janousek J. Leitlinie DGPK: Bradykarde Herzrhythmusstörungen im Kindes- und Jugendalter sowie bei jungen Erwachsenen mit einem angeborenen Herzfehler (EMAH). https://wwwdgpkorg/fileadmin/user_upload/Leitlinien/2019_09_04_LL-Bradykardie_finalpdf 2019
    PubMed
  • 58 Paul T, Gebauer R, Kriebel T. et al. Leitlinie DGKP: Tachykarde Herzrhythmusstörungen. https://wwwdgpkorg/fileadmin/user_upload/Leitlinien/Leitlinie_Tachykardien_DGPK_2018_11_28_finalpdf 2018
    PubMed
  • 59 Janousek J, Ruschewski W, Paul T. Leitlinie DGPK: Leitlinie Pädiatrische Kardiologie: Ventrikuläre Tachykardien und Prävention des plötzlichen Herztodes – Indikationen zur ICD Therapie. https://wwwdgpkorg/fileadmin/user_upload/Leitlinien/2019_04_10_Beschluss_LL-ICD-04-04-2019__2_pdf 2019
    PubMed
  • 60 Maisch B, Pankuweit S. Inflammatory dilated cardiomyopathy : Etiology and clinical management. Herz 2020; 45: 221-229
    CrossrefPubMedGoogle Scholar
  • 61 Bhatt GC, Sankar J, Kushwaha KP. Use of intravenous immunoglobulin compared with standard therapy is associated with improved clinical outcomes in children with acute encephalitis syndrome complicated by myocarditis. Pediatr Cardiol 2012; 33: 1370-1376
    CrossrefPubMedGoogle Scholar
  • 62 Robinson JL, Hartling L, Crumley E. et al. A systematic review of intravenous gamma globulin for therapy of acute myocarditis. BMC Cardiovasc Disord 2005; 5: 12
    CrossrefPubMedGoogle Scholar
  • 63 Drucker NA, Colan SD, Lewis AB. et al. Gamma-globulin treatment of acute myocarditis in the pediatric population. Circulation 1994; 89: 252-257
    CrossrefPubMedGoogle Scholar
  • 64 Heidendael JF, Den Boer SL, Wildenbeest JG. et al. Intravenous immunoglobulins in children with new onset dilated cardiomyopathy. Cardiology in the young 2018; 28: 46-54
    CrossrefPubMedGoogle Scholar
  • 65 Haque A, Bhatti S, Siddiqui FJ. Intravenous immune globulin for severe acute myocarditis in children. Indian Pediatr 2009; 46: 810-811
    PubMedGoogle Scholar
  • 66 Robinson J, Hartling L, Vandermeer B. et al. Intravenous immunoglobulin for presumed viral myocarditis in children and adults. Cochrane Database Syst Rev 2020; 8: CD004370
    PubMedGoogle Scholar
  • 67 Hazebroek MR, Henkens M, Raafs AG. et al. Intravenous immunoglobulin therapy in adult patients with idiopathic chronic cardiomyopathy and cardiac parvovirus B19 persistence: a prospective, double-blind, randomized, placebo-controlled clinical trial. Eur J Heart Fail 2021; 23: 302-309
    CrossrefPubMedGoogle Scholar
  • 68 Kandolf R. [Diagnosis of myocarditis]. Dtsch Med Wochenschr 2011; 136: 829-835
    PubMedGoogle Scholar
  • 69 Tschope C, Muller I, Xia Y. et al. NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced Myocarditis. Circ Heart Fail 2017; 10
    PubMedGoogle Scholar
  • 70 De Luca G, Cavalli G, Campochiaro C. et al. Myocarditis: An Interleukin-1-Mediated Disease?. Front Immunol 2018; 9: 1335
    CrossrefPubMedGoogle Scholar
  • 71 Luconi N, Risse J, Busato T. et al. Myocarditis in a young man with adult onset Still’s disease successfully treated with Il-1 blocker. Int J Cardiol 2015; 189: 220-222
    CrossrefPubMedGoogle Scholar
  • 72 Henderson LA, Canna SW, Friedman KG. et al. American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 2. Arthritis Rheumatol 2021; 73: e13-e29
    CrossrefPubMedGoogle Scholar
  • 73 Harwood R, Allin B, Jones CE. et al. A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process. Lancet Child Adolesc Health 2021; 5: 133-141
    CrossrefPubMedGoogle Scholar
  • 74 Muller J, Wallukat G, Dandel M. et al. Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation 2000; 101: 385-391
    CrossrefPubMedGoogle Scholar
  • 75 Wallukat G, Muller J, Hetzer R. Specific removal of beta1-adrenergic autoantibodies from patients with idiopathic dilated cardiomyopathy. N Engl J Med 2002; 347: 1806
    CrossrefPubMedGoogle Scholar
  • 76 Ameling S, Bhardwaj G, Hammer E. et al. Changes of myocardial gene expression and protein composition in patients with dilated cardiomyopathy after immunoadsorption with subsequent immunoglobulin substitution. Basic Res Cardiol 2016; 111: 53
    CrossrefPubMedGoogle Scholar
  • 77 Costanzo-Nordin MR, Reap EA, O’Connell JB. et al. A nonsteroid anti-inflammatory drug exacerbates Coxsackie B3 murine myocarditis. Journal of the American College of Cardiology 1985; 6: 1078-1082
    CrossrefPubMedGoogle Scholar
  • 78 Adler Y, Charron P, Imazio M. et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2015; 36: 2921-2964
    CrossrefPubMedGoogle Scholar
  • 79 Schultheiss HP, Piper C, Sowade O. et al. Betaferon in chronic viral cardiomyopathy (BICC) trial: Effects of interferon-beta treatment in patients with chronic viral cardiomyopathy. Clin Res Cardiol 2016; 105: 763-773
    CrossrefPubMedGoogle Scholar
  • 80 Escher F, Kuhl U, Lassner D. et al. Long-term outcome of patients with virus-negative chronic myocarditis or inflammatory cardiomyopathy after immunosuppressive therapy. Clin Res Cardiol 2016; 105: 1011-1020
    CrossrefPubMedGoogle Scholar
  • 81 Merken J, Hazebroek M, Van Paassen P. et al. Immunosuppressive Therapy Improves Both Short- and Long-Term Prognosis in Patients With Virus-Negative Nonfulminant Inflammatory Cardiomyopathy. Circ Heart Fail 2018; 11: e004228
    CrossrefPubMedGoogle Scholar
  • 82 Frustaci A, Russo MA, Chimenti C. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J 2009; 30: 1995-2002
    CrossrefPubMedGoogle Scholar
  • 83 Gagliardi MG, Bevilacqua M, Bassano C. et al. Long term follow up of children with myocarditis treated by immunosuppression and of children with dilated cardiomyopathy. Heart 2004; 90: 1167-1171
    CrossrefPubMedGoogle Scholar
  • 84 Aziz KU, Patel N, Sadullah T. et al. Acute viral myocarditis: role of immunosuppression: a prospective randomised study. Cardiology in the young 2010; 20: 509-515
    CrossrefPubMedGoogle Scholar
  • 85 Camargo PR, Okay TS, Yamamoto L. et al. Myocarditis in children and detection of viruses in myocardial tissue: implications for immunosuppressive therapy. Int J Cardiol 2011; 148: 204-208
    CrossrefPubMedGoogle Scholar
  • 86 He B, Li X, Li D. Immunosuppressive Treatment for Myocarditis in the Pediatric Population: A Meta-Analysis. Front Pediatr 2019; 7: 430
    CrossrefPubMedGoogle Scholar
  • 87 Hetzer R, Stiller B. Technology insight: Use of ventricular assist devices in children. Nat Clin Pract Cardiovasc Med 2006; 3: 377-386
    CrossrefPubMedGoogle Scholar
  • 88 Spillmann F, Van Linthout S, Schmidt G. et al. Mode-of-action of the PROPELLA concept in fulminant myocarditis. Eur Heart J 2019; 40: 2164-2169
    CrossrefPubMedGoogle Scholar
  • 89 Schmaltz AA, Demel KP, Kallenberg R. et al. Immunosuppressive therapy of chronic myocarditis in children: three cases and the design of a randomized prospective trial of therapy. Pediatr Cardiol 1998; 19: 235-239
    CrossrefPubMedGoogle Scholar
  • 90 Pelliccia A, Solberg EE, Papadakis M. et al. Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC). Eur Heart J 2019; 40: 19-33
    CrossrefPubMedGoogle Scholar
  • 91 Maron BJ, Udelson JE, Bonow RO. et al. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology. Circulation 2015; 132: e273-e280
    PubMedGoogle Scholar
  • 92 Gati S, Sharma S, Pennell D. The Role of Cardiovascular Magnetic Resonance Imaging in the Assessment of Highly Trained Athletes. JACC Cardiovasc Imaging 2018; 11: 247-259
    CrossrefPubMedGoogle Scholar